Unilabs launches innovative health App

Unilabs launches innovative health App allowing customers to schedule appointments and receive Covid-19 results

Unilabs, the leading European diagnostic group, has announced the launch of its innovative and pioneering new health App “Unilabs ME”.

The mobile app providing a new experience for the customer, increasing convenience, security, and simplifying and streamlining the entire covid-19 testing process and results delivery.

The Unilabs ME app was developed in partnership with 7egend, Cristiano Ronaldo´s agency, that is a reference in digital transformation, with brands in their portfolio such as Unilabs, CR7, FNAC, Aser Ventures, Valencia CF, Portuguese Football Federation, Levi´s, McDonald´s, FC Porto, Altice or Footlab.

The partnership with Cristiano Ronaldo’s digital agency is part of Unilabs’s expansion plans as a premium brand and represents a strong impetus to the international efforts being made to counter the Covid-19 pandemic.

The app will allow customers to schedule and make an appointment for Covid-19 testing in Unilabs units. This new process will reduce waiting times in the testing process, as customers will have access to a check-in QRcode that the clinic will use to quickly admit the patient, avoiding the hassle of bureaucratic processes and unnecessary contacts.

Within a maximum period of 6 hours, customers will receive their test results in the new Unilabs ME App, by email and SMS.

Commenting on the launch of the Unilabs ME App, Mohamed Daoud, CEO of Unilabs UAE said: “We are extremely proud of our partnership with the digital agency of the legend player Cristiano Ronaldo, which is part of ongoing endeavors to improve customer experience and provide better service and convenience.

Daoud affirmed that the newly launched app is another milestone of our business to consumer strategy, with many other digital and technological initiatives already on the roadmap, pursuing innovation always with a customer-centric approach, most notably the agreement with the International Air Transport Association (IATA) to incorporate Unilabs’ worldwide COVID-19 testing network into IATA Travel Pass, making the process seamless, secure, and easy.

“We are eager to hold more partnership with the most popular public figures, as this will make our projects and initiatives more holistic and successful. Meanwhile, we work tirelessly to support the UAE’s strenuous efforts to expand the scope of Covid-19 tests, under the supervision of health authorities on the quality and efficiency of laboratory testing services, and the use of digital and medical technology innovations in accordance with international best practices to ensure that medical tests are being conducted in an effective and high-quality environment,” he concluded.

For his part, Luis Parafita CEO of 7egend, said: ““It is with great pleasure that a 7egend joined Unilabs UAE in this journey for the digital transformation of the brand in the region. Sharing the strategic vision, working across the board with teams and adding value to the entire ecosystem, we all work with a common goal at the top of the priorities, a customer-centric approach.

“This first phase culminates with the launch of the first version of the native mobile app, developed for iOS and Android, and designed to provide customers with a top notch experience, a reference in the healthcare industry. This first and very important milestone in the brand’s digital transformation strategy, increases the efficiency, provides more comfort and convenience, innovates, and delivers better service to customers. The future is bright, the ambition is high and 7egend will walk side by side with Unilabs on this path,” Parafita added.

About Unilabs

Unilabs is one of Europe’s largest diagnostics companies. It offers a complete range of laboratory, pathology and imaging services for patients all around the world. With 12,700 employees across 150 imaging centres and 250 labs in 17 countries, we perform more than four million lab tests a week – saving lives every single day.